Documentation
Categories
< All Topics
Print

Indian Regulatory Approval Process

UpdatedFebruary 16, 2023

The Indian regulatory approval process for drugs and medical devices is a multi-step process that is designed to ensure the safety, efficacy, and quality of these products before they can be marketed and sold in India. The steps in the Indian regulatory approval process include:

  1. Pre-Clinical Studies: The first step in the approval process is the conduct of pre-clinical studies, which are conducted to evaluate the safety and efficacy of a new drug or medical device.
  2. Clinical Trials: After the successful completion of pre-clinical studies, the next step is the conduct of clinical trials. Clinical trials are conducted to further evaluate the safety and efficacy of the drug or medical device in human subjects.
  3. New Drug Application (NDA): After the successful completion of clinical trials, the manufacturer must submit a New Drug Application (NDA) to the Central Drugs Standard Control Organization (CDSCO) for review and approval. The NDA must include data from pre-clinical studies and clinical trials, as well as information on the manufacturing process and the quality control measures in place.
  4. Review and Approval: Once the NDA is received, the CDSCO will review the data and determine whether the drug or medical device is safe, efficacious, and of high quality. If the CDSCO determines that the product meets these standards, it will grant approval for marketing and sale in India.
  5. Post-Market Monitoring: After a drug or medical device is approved for marketing and sale, the CDSCO will monitor the product through post-marketing surveillance to ensure that it continues to be safe and effective.

In conclusion, the Indian regulatory approval process for drugs and medical devices is designed to ensure the safety, efficacy, and quality of these products before they can be marketed and sold in India. The process involves a series of steps, including pre-clinical studies, clinical trials, submission of a New Drug Application, review and approval by the CDSCO, and post-market monitoring.

You may be interested in the programs below: